blonder8k042114.htm

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K
 
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): April 21, 2014
 
 
               Blonder Tongue Laboratories, Inc.                
(Exact Name of registrant as specified in its charter)
 
 
 
           Delaware            
(State or other jurisdiction of incorporation)
 
 
 
 1-14120
(Commission File Number)
 
 
 
52-1611421
(I.R.S. Employer Identification No.)
 
One Jake Brown Road, Old Bridge, New Jersey  08857   
(Address of principal executive offices)  (Zip Code)
 
 
 
Registrant’s telephone number, including area code:   (732) 679-4000
 
Not Applicable
(Former name or former address, if changed since last report)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 

 

Item 8.01  Other Events.

On April 21, 2014, the Company issued a press release announcing that it had received a favorable ruling in the K Tech patent litigation.  The press release is attached hereto as Exhibit 99.1.


Item 9.01.  Financial Statements and Exhibits.

(d)                 The following exhibits are filed herewith:
 
Exhibit 99.1                           Press Release dated April 21, 2014.
 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


BLONDER TONGUE LABORATORIES, INC.


By:   /s/ Eric Skolnik                                                
     Eric Skolnik
     Senior Vice President and Chief Financial Officer
 
Date: April 21, 2014

 



EXHIBIT INDEX


Exhibit No.                                Description

Exhibit 99.1                                Press Release of Blonder Tongue Laboratories, Inc. dated April 21, 2014.




2